3Peyrot M, Rubin RR. Levels and risks of depression and anx2iety symptomatology among diabetic adults[J]. Diabetes Care, 1997,20(4) :585 - 590.
4Glasgow RE, Ruggiero L, Eakin EG, et al. Quality of life an- dassoeiated ctmracterisfics in a large national sample of adult swith diabetes[J]. Diabetes Care, 1997,20(4) :562 - 567.
2Sinclair AJ,Allard I,Bayer A. Observation of diabetes care in longterm institutional settings with measures of cognitive function and dependency [J]. Diabetes Care, 1997,5 : 778-784.
3Leibson CL, Rocca WA, Hanson VA, et al. Risk of dementia among persons with diabetes mellitus:A population-based cohort study[J]. Am J Epidemiol, 1997,145:301-308.
4Schenk D, Barbour R, Dunn W,et al. Immunization with amyloid-βattenuates Alzheimer's-disease-like pathology in the PDAPP mouse[J]. Nature, 1999;400: 173-177.
5Lemere CA, Maron R, Spooner ET,et aL Nasal Aβ immunization reduces amyloid-βprotein burden in PDAPP mice[J]. Neurobiol Aging, 2000,21:S126.
6Zhao YM, Pei JJ, Ji ZJ,et al. Effect of amyloid precursor protein 17mer peptide on microtubule structure and tau protein hyperphosphorylation in hippocampal neurons of experimental diabetic mice[J]. Neurol Report, 2003,14 : 61-6.
7Sheng SL, Zhao YM, Zhao ZW, et al.β-amyloid and its binding protein in the hippocampus of diabetic mice: Effect of APP 17 peptide[J]. Neurol Report, 2001,12:3317-9.
8Ott A, Stolk RP. Hofman A, et al. Association of diabetes mellitus and dementia: The Rotterdam study[J]. Diabetologia,1996,11:1392-7.
9Wales JK. Does psychological stress diabetes?. Diabet Med,1995,12: 109-111.
10Peyrot M,Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care,1997,20(4): 585-590.
